Clinical Trial Update: Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating chemotherapy, irradiation, cell infusions, and interleukin-2 for metastatic melanoma. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2012-10-18